Phase I Trial of Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
NCT07107750 · RECRUITING · Phase 1
We track 8 ClinicalTrials.gov studies led by Washington University School Of Medicine. The portfolio skews toward Phase 3 (5 trials).
8 clinical trials sponsored by Washington University School Of Medicine.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 3 | 5 | 63% |
| N/A | 2 | 25% |
| Phase 1 | 1 | 13% |
Washington University School Of Medicine currently sponsors 8 clinical trials tracked on ReadTheTrial. These span Phase 3, N/A, Phase 1.
Washington University School Of Medicine conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Washington University School Of Medicine currently has 3 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.